Nils E Magnusson
Overview
Explore the profile of Nils E Magnusson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
708
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pedersen T, Fojan P, Pedersen A, Magnusson N, Gurevich L
Biosensors (Basel)
. 2023 May;
13(5).
PMID: 37232880
State-of-the-art clinical detection methods typically involve standard immunoassay methods, requiring specialized equipment and trained personnel. This impedes their use in the Point-of-Care (PoC) environment, where ease of operation, portability, and...
2.
Prasad B, Grimm D, Strauch S, Erzinger G, Corydon T, Lebert M, et al.
Int J Mol Sci
. 2020 Dec;
21(24).
PMID: 33317046
All life forms have evolved under the constant force of gravity on Earth and developed ways to counterbalance acceleration load. In space, shear forces, buoyance-driven convection, and hydrostatic pressure are...
3.
Coopmans E, El-Sayed N, Frystyk J, Magnusson N, Jorgensen J, van der Lely A, et al.
Endocrine
. 2020 Apr;
69(1):165-174.
PMID: 32333268
Purpose: Although quality of life (QoL) is improved in patients with acromegaly after disease control, QoL correlates only weakly with traditional biomarkers. Our objective is to investigate a potential relation...
4.
Hybel T, Dietrichs D, Sahana J, Corydon T, Nassef M, Wehland M, et al.
Int J Mol Sci
. 2020 Feb;
21(4).
PMID: 32070055
Prostate cancer is one of the leading causes of cancer mortality in men worldwide. An unusual but unique environment for studying tumor cell processes is provided by microgravity, either in...
5.
Moller N, Budolfsen C, Grimm D, Kruger M, Infanger M, Wehland M, et al.
Int J Mol Sci
. 2019 Sep;
20(19).
PMID: 31547602
This paper reviews current treatments for renal cell carcinoma/cancer (RCC) with the multikinase inhibitors (MKIs) sorafenib, sunitinib, lenvatinib and axitinib. Furthermore, it compares these drugs regarding progression-free survival, overall survival...
6.
Dittrich A, Grimm D, Sahana J, Bauer J, Kruger M, Infanger M, et al.
Cell Physiol Biochem
. 2018 Feb;
45(2):429-445.
PMID: 29402845
Background/aims: Cardiovascular complications are common in astronauts returning from a prolonged spaceflight. These health problems might be driven by complex modulations of gene expression and protein synthesis in endothelial cells...
7.
Hypertension Caused by Lenvatinib and Everolimus in the Treatment of Metastatic Renal Cell Carcinoma
Bendtsen M, Grimm D, Bauer J, Wehland M, Wise P, Magnusson N, et al.
Int J Mol Sci
. 2017 Aug;
18(8).
PMID: 28796163
Multikinase inhibitors (MKI) and mammalian target of rapamycin (mTOR) inhibitors prolong progression-free (PFS) and overall survival (OS) in the treatment of metastatic renal cell carcinoma (mRCC) by reducing angiogenesis and...
8.
Randrup Hansen C, Grimm D, Bauer J, Wehland M, Magnusson N
Int J Mol Sci
. 2017 Feb;
18(2).
PMID: 28230776
In recent years, targeted therapies have proven beneficial in terms of progression-free survival (PFS) and overall survival (OS) in the treatment of metastatic renal cell carcinoma (mRCC). The tyrosine kinase...
9.
Corydon T, Mann V, Slumstrup L, Kopp S, Sahana J, Askou A, et al.
Cell Physiol Biochem
. 2016 Nov;
40(1-2):1-17.
PMID: 27842307
Background/aims: Microgravity (µg) has adverse effects on the eye of humans in space. The risk of visual impairment is therefore one of the leading health concerns for NASA. The impact...
10.
Thomsen K, Moller H, Graversen J, Magnusson N, Moestrup S, Vilstrup H, et al.
World J Hepatol
. 2016 Jun;
8(17):726-30.
PMID: 27330681
Aim: To study the effect of a new anti-CD163-dexamethasone conjugate targeting activated macrophages on the hepatic acute phase response in rats. Methods: Wistar rats were injected intravenous with either the...